Effect of a primary care based brief intervention trial among risky drug users on health-related quality of life

Drug and Alcohol Dependence

Volumn 142, Issue , 2014, Pages 254-261

  Baumeister, Sebastian E ^a   Gelberg, Lillian ^b,c,d   Leake, Barbara D ^b   Yacenda Murphy, Julia ^b   Vahidi, Mani ^b   Andersen, Ronald M ^c  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Brief intervention; Illicit drug use; Primary care clinics; Quality of life; Screening

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH COMPONENT SUMMARY SCORE; PHYSICAL HEALTH COMPONENT SUMMARY SCORE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 12; TELEMEDICINE; THERAPY EFFECT; COUNSELING; HEALTH STATUS; HIGH RISK BEHAVIOR; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; PSYCHOLOGY; SINGLE BLIND PROCEDURE; TELECONSULTATION; TREATMENT OUTCOME;

ADULT; COUNSELING; DRUG USERS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF LIFE; REMOTE CONSULTATION; RISK-TAKING; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84905589638     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.06.034     Document Type: Article

References (55)

1. Andersen R., Davidson P., Baumeister S. Improving access to care in America. Changing the U.S. Health Care System 2014, Jossey-Bass, San Francisco, CA. J. Kominski (Ed.).
2. Andrade L.F., Alessi S.M., Petry N.M. The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence. Am. J. Addict. 2012, 21:47-54.
3. Austin P.C., Manca A., Zwarenstein M., Juurlink D.N., Stanbrook M.B. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. J. Clin. Epidemiol. 2010, 63:142-153.
4. Babor T.F., McRee B.G., Kassebaum P.A., Grimaldi P.L., Ahmed K., Bray J. Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst. Abuse 2007, 28:7-30.
5. Bang H., Robins J.M. Doubly robust estimation in missing data and causal inference models. Biometrics 2005, 61:962-973.
6. Becker S.J., Curry J.F., Yang C. Longitudinal association between frequency of substance use and quality of life among adolescents receiving a brief outpatient intervention. Psychol. Addict. Behav. 2009, 23:482-490.
7. Becker S.J., Curry J.F., Yang C. Factors that influence trajectories of change in frequency of substance use and quality of life among adolescents receiving a brief intervention. J. Subst. Abuse Treat. 2011, 41:294-304.
8. Bernstein J., Bernstein E., Tassiopoulos K., Heeren T., Levenson S., Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005, 77:49-59.
9. Crosby R.D., Kolotkin R.L., Williams G.R. Defining clinically meaningful change in health-related quality of life. J. Clin. Epidemiol. 2003, 56:395-407.
10. De Maeyer J., van Nieuwenhuizen C., Bongers I.L., Broekaert E., Vanderplasschen W. Profiles of quality of life in opiate-dependent individuals after starting methadone treatment: a latent class analysis. Int. J. Drug Policy 2013, 24:342-350.
11. De Maeyer J., Vanderplasschen W., Broekaert E. Quality of life among opiate-dependent individuals: a review of the literature. Int. J. Drug Policy 2010, 21:364-380.
12. De Maeyer J., Vanderplasschen W., Lammertyn J., van Nieuwenhuizen C., Broekaert E. Exploratory study on domain-specific determinants of opiate-dependent individuals' quality of life. Eur. Addict. Res. 2011, 17:198-210.
13. De Maeyer J., Vanderplasschen W., Lammertyn J., van Nieuwenhuizen C., Sabbe B., Broekaert E. Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment. Qual. Life Res. 2011, 20:139-150.
14. Donovan D., Mattson M.E., Cisler R.A., Longabaugh R., Zweben A. Quality of life as an outcome measure in alcoholism treatment research. J. Stud. Alcohol Suppl. 2005, 119-139.
15. Donovan D.M. More mice or a better mouse trap? Reflections on primary outcome indices in illicit drug dependence treatment research. Addiction 2012, 107:723-724.
16. Gelberg, L., Andersen, R.M., Leake, B.D., Arangua, L., Vahidi, M., Singelton, K., Yacenda-Murphy, J., Showtaw, S., Fleming, M.F., Baumeister, S.E., submitted. Project QUIT: A primary care based screening and brief intervention efficacy trial to reduce risky drug use. Ann. Int. Med.
17. Gilbert P., Ciccarone D., Gansky S.A., Bangsberg D.R., Clanon K., McPhee S.J., Calderon S.H., Bogetz A., Gerbert B. Interactive Video Doctor counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One 2008, 3:e1988.
18. Goldstein M.G., Whitlock E.P., DePue J. Multiple behavioral risk factor interventions in primary care. Summary of research evidence. Am. J. Prev. Med. 2004, 27:61-79.
19. Gonzales R., Ang A., Marinelli-Casey P., Glik D.C., Iguchi M.Y., Rawson R.A. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period. J. Subst. Abuse Treat. 2009, 37:353-361. A Methamphetamine Treatment Project Corporate.
20. Heckman J.J., Vytlacil E. Policy-relevant treatment effects. Am. Econ. Rev. 2001, 91:107-111.
21. Heslin K.C., Stein J.A., Heinzerling K.G., Pan D., Magladry C., Hays R.D. Clinical correlates of health-related quality of life among opioid-dependent patients. Qual. Life Res. 2011, 20:1205-1213.
22. Holland R., Maskrey V., Swift L., Notley C., Robinson A., Nagar J., Gale T., Kouimtsidis C. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial. Addiction 2014, 109:596-607.
23. Humeniuk R., Ali R., Babor T., Souza-Formigoni M.L., de Lacerda R.B., Ling W., McRee B., Newcombe D., Pal H., Poznyak V., Simon S., Vendetti J. A randomized controlled trial of a brief intervention for illicit drugs linked to the alcohol, smoking and substance involvement screening test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012, 107:957-966.
24. Humeniuk R., Ali R., Babor T.F., Farrell M., Formigoni M.L., Jittiwutikarn J., de Lacerda R.B., Ling W., Marsden J., Monteiro M., Nhiwatiwa S., Pal H., Poznyak V., Simon S. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction 2008, 103:1039-1047.
25. Humeniuk R., Ali R. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and Pilot Brief Intervention [electronic resource]: A Technical Report of phase II findings of the WHO ASSIST Project 2006, W.H.O.A.P.I.S. Group, World Health Organization, Geneva.
26. Humeniuk R., Dennington V., Ali R. The Effectiveness of a Brief Intervention for Illicit Drugs Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in Primary Health Care Settings: A Technical Report of Phase III Findings of the WHO ASSIST Randomized Controlled Trial 2008, World Health Organization, Geneva.
27. Humphreys K., McLellan A.T. Brief intervention, treatment, and recovery support services for Americans who have substance use disorders: an overview of policy in the Obama administration. Psychol. Serv. 2010, 7:275-284.
28. Jaeschke R., Singer J., Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin. Trials 1989, 10:407-415.
29. John U., Ulbricht S., Freyer-Adam J., Meyer C. Needs for Chronic Disease Prevention in Germany 2013, Nationale Akademie der Wissenschaften Leopoldina, Halle.
30. Kamerow D.B., Pincus H.A., Macdonald D.I. Alcohol abuse, other drug abuse, and mental disorders in medical practice. Prevalence, costs, recognition, and treatment. JAMA 1986, 255:2054-2057.
31. Laudet A.B. The case for considering quality of life in addiction research and clinical practice. Addict. Sci. Clin. Pract. 2011, 6:44-55.
32. Laudet A.B., Becker J.B., White W.L. Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Subst. Use Misuse 2009, 44:227-252.
33. Lev-Ran S., Imtiaz S., Taylor B.J., Shield K.D., Rehm J., Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2012, 123:190-200.
34. McNeely J., Strauss S.M., Wright S., Rotrosen J., Khan R., Lee J.D., Gourevitch M.N. Test-retest reliability of a self-administered alcohol, smoking and substance involvement screening test (ASSIST) in primary care patients. J. Subst. Abuse Treat. 2014, 47:93-101.
35. Miller P.G., Miller W.R. What should we be aiming for in the treatment of addiction?. Addiction 2009, 104:685-686.
36. Morgan T.J., Morgenstern J., Blanchard K.A., Labouvie E., Bux D.A. Health-related quality of life for adults participating in outpatient substance abuse treatment. Am. J. Addict. 2003, 12:198-210.
37. Morgenstern J., Blanchard K.A., Morgan T.J., Labouvie E., Hayaki J. Testing the effectiveness of cognitive-behavioral treatment for substance abuse in a community setting: within treatment and posttreatment findings. J. Consult. Clin. Psychol. 2001, 69:1007-1017.
38. Newman R.G. Comment on the case for considering quality of life in addiction research and clinical practice. Addict. Sci. Clin. Pract. 2012, 7(2):1-2. author reply 2.
39. Parker S.L., Adogwa O., Mendenhall S.K., Shau D.N., Anderson W.N., Cheng J.S., Devin C.J., McGirt M.J. Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis. Spine J. 2012, 12:1122-1128.
40. Revicki D., Hays R.D. Reliability and validity (including reponsiveness). Assessing Quality of Life in Clinical Trials: Methods and Practice 2004, 25-39. Oxford University Press, New York, NY. P.M. Fayers, R.D. Hays (Eds.).
41. Revicki D., Hays R.D., Cella D., Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J. Clin. Epidemiol. 2008, 61:102-109.
42. Saitz R., Alford D.P., Bernstein J., Cheng D.M., Samet J., Palfai T. Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed. J. Addict. Med. 2010, 4:123-130.
43. Stout R.L., Wirtz P.W., Carbonari J.P., Del Boca F.K. Ensuring balanced distribution of prognostic factors in treatment outcome research. J. Stud. Alcohol Suppl. 1994, 12:70-75.
44. Tracy E.M., Laudet A.B., Min M.O., Kim H., Brown S., Jun M.K., Singer L. Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug Alcohol Depend. 2012, 124:242-249.
45. U.S.Department of Justice, National Drug Intelligence Center The Economic Impact of Illicit Drug Use on American Society 2011, U.S. Department of Justice, Washington, DC.
46. Velentgas P., Dreyer N.A., Nourja P. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide 2013, United States Agency for Healthcare Research and Quality, Rockville, MD.
47. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34:220-233.
48. Ware J.E., Kosinski M., Keller S.D. Sf-12: How To Score The Sf-12 Physical And Mental Health Summary Scales 1995, Health Institute, New England Medical Center, Boston, MA.
49. White I.R., Carpenter J., Horton N.J. Including all individuals is not enough: lessons for intention-to-treat analysis. Clin. Trials 2012, 9:396-407.
50. White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: Issues and guidance for practice. Stat. Med. 2011, 30:377-399.
51. Wiebe S., Matijevic S., Eliasziw M., Derry P.A. Clinically important change in quality of life in epilepsy. J. Neurol. Neurosurg. Psychiatry 2002, 73:116-120.
52. Wilson I.B., Cleary P.D. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995, 273:59-65.
53. Wooldridge J.M. Econometric Analysis of Cross-Sectional and Panel Data 2010, MIT Press, Cambridge, MA.
54. World Health Organization The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc. Sci. Med. 1995, 41:1403-1409.
55. World Health Organization Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol. Med. 1998, 28:551-558.